$15.11—Stale · unknown old
NASDAQ • Last print unknown ago
$15.11—Stale · unknown old
Columbia Small Cap Value and Inflection Fund;A (COVAX) focuses on investing in small-cap value stocks, primarily within the U.S. market. The fund's competitive position is bolstered by its experienced management team and a disciplined investment approach that seeks to identify undervalued companies with strong growth potential.
COVAX generates revenue primarily through management fees based on a percentage of AUM. The fund's strategy emphasizes value investing in small-cap stocks, which allows it to capitalize on market inefficiencies. The experienced management team enhances its competitive advantage through rigorous research and a long-term investment horizon.
Changes in AUM driven by market performance and investor inflows
Performance relative to benchmark indices, particularly small-cap value indices
Market sentiment towards small-cap stocks
Regulatory changes affecting asset management fees
Potential regulatory changes impacting asset management fees and practices
Market volatility affecting small-cap stock performance
Increased competition from passive investment vehicles such as ETFs
Pressure on fees from larger asset managers
Limited financial leverage, but exposure to market downturns can impact AUM and revenue
high - Small-cap stocks typically perform well during economic expansions as they are more sensitive to domestic economic growth.
Rising interest rates can increase financing costs for small-cap companies, potentially impacting their growth and profitability, which may lead to reduced investor interest in small-cap funds like COVAX.
minimal - The fund's operations are not heavily reliant on credit markets, but broader credit conditions can influence investor sentiment and inflows.
value - Investors seeking exposure to undervalued small-cap stocks with growth potential.
moderate - Historically, small-cap funds exhibit higher volatility compared to large-cap funds.